Epic Sciences Secures $13,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a0e580b-0e07-4d1b-994a-b4b1347b15ae&Preview=1 -
Date
11/13/2012 -
Company Name
Epic Sciences -
Mailing Address
3565 General Atomics Court San Diego, CA 92121 -
Company Description
The company manufactures analytical laboratory instruments. -
Website
http://www.epicsciences.com -
Transaction Type
Venture Equity -
Transaction Amount
$13,000,000 -
Transaction Round
Series B -
Proceeds Purposes
With the proceeds from the financing, Epic will expand research and development operations and capabilities to commercialize the company’s CTC platform, the basis of which has been exclusively licensed from Dr. Peter Kuhn’s laboratory at The Scripps Research Institute. -
M&A Terms
-
Venture Investor
Domain Associates -
Venture Investor
Roche Venture Fund -
Venture Investor
Pfizer Venture Investments
